Strategic Partnerships ProgenaCare has recently engaged in asset transactions and distribution partnerships, including selling assets to BioStem Technologies and a distribution arrangement for revyve Antimicrobial Wound Gel. This suggests growth through strategic alliances and potential co-selling or sublicensing opportunities with distributors and complementary wound care players.

Global Expansion The company has a track record of expanding offices and initiating programs in new regions such as the Middle East, Africa (Uganda, Rwanda), and the Americas, indicating a readiness to explore new markets. This presents sales opportunities for regional distributors, clinical partners, and hospital networks in emerging markets.

Affordable Innovation ProgenaCare markets ProgenaMatrix as a cost-effective, keratin-based wound care solution with a unique technology platform. This positions the company well to pursue budget-conscious healthcare systems, public hospitals, and value-based care programs seeking advanced wound care at a lower total cost of ownership.

Patient Access With the CaringAccess Patient Assistance Program enabling no-cost access for qualifying patients, there is an opportunity to partner with payer systems, NGOs, and public health initiatives to broaden adoption in underserved populations and to drive visibility in markets with reimbursement challenges.

Growth Through Outreach Recent leadership changes and a focus on global export recognition suggest a company poised for outbound sales expansion. This supports targeted outreach to healthcare networks, wound care centers, and regional distributors aligned with tissue viability and chronic wound management to accelerate channel development.